NL191208C - 4-Amino-6,7-dimethoxy-2-[4-(gesubstitueerd carbonyl)-1-piperazinylchinazoline-verbindingen met hypertensie bestrijdende werkzaamheid en farmaceutische preparaten, die deze verbindingen bevatten. - Google Patents

4-Amino-6,7-dimethoxy-2-[4-(gesubstitueerd carbonyl)-1-piperazinylchinazoline-verbindingen met hypertensie bestrijdende werkzaamheid en farmaceutische preparaten, die deze verbindingen bevatten.

Info

Publication number
NL191208C
NL191208C NL8100726A NL8100726A NL191208C NL 191208 C NL191208 C NL 191208C NL 8100726 A NL8100726 A NL 8100726A NL 8100726 A NL8100726 A NL 8100726A NL 191208 C NL191208 C NL 191208C
Authority
NL
Netherlands
Prior art keywords
compounds
piperazinylquinazoline
dimethoxy
amino
pharmaceutical compositions
Prior art date
Application number
NL8100726A
Other languages
English (en)
Dutch (nl)
Other versions
NL8100726A (nl
NL191208B (nl
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1677580A external-priority patent/JPS56113770A/ja
Priority claimed from JP5275480A external-priority patent/JPS56150072A/ja
Priority claimed from JP9610680A external-priority patent/JPS5721384A/ja
Priority claimed from JP9610780A external-priority patent/JPS5721385A/ja
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NL8100726A publication Critical patent/NL8100726A/nl
Publication of NL191208B publication Critical patent/NL191208B/xx
Application granted granted Critical
Publication of NL191208C publication Critical patent/NL191208C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8100726A 1980-02-13 1981-02-13 4-Amino-6,7-dimethoxy-2-[4-(gesubstitueerd carbonyl)-1-piperazinylchinazoline-verbindingen met hypertensie bestrijdende werkzaamheid en farmaceutische preparaten, die deze verbindingen bevatten. NL191208C (nl)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP1677580 1980-02-13
JP1677580A JPS56113770A (en) 1980-02-13 1980-02-13 Novel quinazoline derivative and its preparation
JP5275480A JPS56150072A (en) 1980-04-21 1980-04-21 Novel quinazoline derivative and its preparation
JP5275480 1980-04-21
JP9610680A JPS5721384A (en) 1980-07-14 1980-07-14 Novel aminoquinazoline derivative and its preparation
JP9610780 1980-07-14
JP9610680 1980-07-14
JP9610780A JPS5721385A (en) 1980-07-14 1980-07-14 Novel aminoquinazoline derivative and its preparation

Publications (3)

Publication Number Publication Date
NL8100726A NL8100726A (nl) 1981-09-16
NL191208B NL191208B (nl) 1994-10-17
NL191208C true NL191208C (nl) 1995-03-16

Family

ID=27456647

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8100726A NL191208C (nl) 1980-02-13 1981-02-13 4-Amino-6,7-dimethoxy-2-[4-(gesubstitueerd carbonyl)-1-piperazinylchinazoline-verbindingen met hypertensie bestrijdende werkzaamheid en farmaceutische preparaten, die deze verbindingen bevatten.

Country Status (9)

Country Link
US (1) US4426382A (cg-RX-API-DMAC7.html)
CA (1) CA1154765A (cg-RX-API-DMAC7.html)
CH (1) CH644857A5 (cg-RX-API-DMAC7.html)
DE (1) DE3105330A1 (cg-RX-API-DMAC7.html)
ES (1) ES8207169A1 (cg-RX-API-DMAC7.html)
FR (1) FR2475548A1 (cg-RX-API-DMAC7.html)
GB (1) GB2068961B (cg-RX-API-DMAC7.html)
IT (1) IT1172225B (cg-RX-API-DMAC7.html)
NL (1) NL191208C (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS236097B1 (en) * 1983-06-01 1985-05-15 Jan Koenig Acylderivatives of 2-piperazinochinazoline and method of their preparation
DE3346675A1 (de) * 1983-12-23 1985-07-04 Beiersdorf Ag, 2000 Hamburg Substituierte 1-(4-amino-6,7-dialkoxy-chinazolinyl)-4- cyclohexenyl-derivate des piperazins und homopiperazins, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen und zwischenprodukte
JPH0647540B2 (ja) * 1985-07-16 1994-06-22 エーザイ株式会社 虚血性心疾患・不整脈治療・予防剤
IT1270993B (it) * 1994-03-18 1997-05-26 Recordati Chem Pharm Derivati chinzolilamminici attivi come alfa-antagonisti
TWI350168B (en) * 2004-05-07 2011-10-11 Incyte Corp Amido compounds and their use as pharmaceuticals
WO2007126935A2 (en) * 2006-03-29 2007-11-08 Merck & Co., Inc. Diazepan orexin receptor antagonists
PE20081229A1 (es) * 2006-12-01 2008-08-28 Merck & Co Inc Antagonistas de receptor de orexina de diazepam sustituido
EP2155689B1 (en) 2007-05-31 2015-07-08 Boehringer Ingelheim International GmbH Ccr2 receptor antagonists and uses thereof
US20090325964A1 (en) * 2008-05-23 2009-12-31 Wyeth Piperazine Metabotropic Glutamate Receptor 5 (MGLUR5) Negative Allosteric Modulators For Anxiety/Depression
PE20120061A1 (es) 2008-12-19 2012-02-19 Boehringer Ingelheim Int Derivados de pirimidina como antagonistas del receptor ccr2
WO2011073154A1 (en) 2009-12-17 2011-06-23 Boehringer Ingelheim International Gmbh New ccr2 receptor antagonists and uses thereof
WO2011141474A1 (en) 2010-05-12 2011-11-17 Boehringer Ingelheim International Gmbh Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
JP5646736B2 (ja) 2010-05-12 2014-12-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規ｃｃｒ２受容体アンタゴニスト、これらの製造方法、及び薬物としてのこれらの使用
US8841313B2 (en) 2010-05-17 2014-09-23 Boehringer Ingelheim International Gmbh CCR2 antagonists and uses thereof
US9018212B2 (en) 2010-05-25 2015-04-28 Boehringer Ingelheim International Gmbh Pyridazine carboxamides as CCR2 receptor antagonists
WO2011151251A1 (en) 2010-06-01 2011-12-08 Boehringer Ingelheim International Gmbh New ccr2 antagonists
WO2013010839A1 (en) 2011-07-15 2013-01-24 Boehringer Ingelheim International Gmbh Novel and selective ccr2 antagonists
AU2013241854B2 (en) * 2012-03-28 2017-11-02 Intervet International B.V. Heteroaryl compounds with cyclic bridging unit for use in the treatment helminth infection
US9452990B2 (en) 2012-06-20 2016-09-27 Novartis Ag Complement pathway modulators and uses thereof
WO2015095111A1 (en) 2013-12-18 2015-06-25 Merck Sharp & Dohme Corp. Diazepane orexin receptor antagonists
EP3317270B1 (en) 2015-07-02 2020-05-13 Centrexion Therapeutics Corporation (4-((3r,4r)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2r,6s)-6-(p-tolyl)tetrahydro-2h-pyran-2-yl)methylamino)pyrimidin-4yl)methanone citrate
EP3648766A4 (en) * 2017-07-06 2021-07-07 Case Western Reserve University PEPTIDIC AND SMALL MOLECULE AGONISTS OF WPHA AND THEIR USES

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3635979A (en) 1969-09-29 1972-01-18 Pfizer Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines
JPS536156B2 (cg-RX-API-DMAC7.html) * 1972-10-30 1978-03-04
US3935213A (en) 1973-12-05 1976-01-27 Pfizer Inc. Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives
US4001237A (en) * 1976-02-18 1977-01-04 Bristol-Myers Company Oxazole, isoxazole, thiazole and isothiazole amides
US4060615A (en) * 1976-02-18 1977-11-29 Mead Johnson & Company 2-Piperazinyl-6,7-dimethoxyquinazolines
US4189484A (en) * 1977-11-08 1980-02-19 Mitsubishi Yuka Pharmaceutical Co., Ltd. Antihypertensive quinazoline derivatives
US4287341A (en) 1979-11-01 1981-09-01 Pfizer Inc. Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
JPS5728576A (en) * 1980-07-24 1982-02-16 Toshiba Corp Inverter device

Also Published As

Publication number Publication date
DE3105330C2 (cg-RX-API-DMAC7.html) 1991-07-25
GB2068961B (en) 1983-11-30
CH644857A5 (de) 1984-08-31
FR2475548A1 (fr) 1981-08-14
ES499377A0 (es) 1982-09-01
NL8100726A (nl) 1981-09-16
FR2475548B1 (cg-RX-API-DMAC7.html) 1983-06-24
NL191208B (nl) 1994-10-17
IT8167213A0 (it) 1981-02-13
CA1154765A (en) 1983-10-04
GB2068961A (en) 1981-08-19
ES8207169A1 (es) 1982-09-01
IT1172225B (it) 1987-06-18
US4426382A (en) 1984-01-17
DE3105330A1 (de) 1981-12-17

Similar Documents

Publication Publication Date Title
NL191208C (nl) 4-Amino-6,7-dimethoxy-2-[4-(gesubstitueerd carbonyl)-1-piperazinylchinazoline-verbindingen met hypertensie bestrijdende werkzaamheid en farmaceutische preparaten, die deze verbindingen bevatten.
NL192343B (nl) 17Ó-gesubstitueerde androsta-(1,)4-(di)een-3-on-17ß-carbonzuurverbindingen met een ontstekingswerende werkzaamheid en farmaceutische preparaten, die deze verbindingen bevatten.
FI813734A7 (fi) Farmaseuttiset koostumukset.
DE3863442D1 (de) Sukroseester enthaltende, die hautpermeabilitaet vergroessernde zusammensetzungen.
NL190757C (nl) 4-(3-Chloorfenyl)-1-piperazinylpropyl gesubstitueerde-1,2,4-triazool-3-on verbindingen met antidepressieve werking en farmaceutische preparaten daarvan.
IT8322171A0 (it) Composizioni analgesiche, e antiinfiammatorie migliorate, contenenti caffeina.
DE3575070D1 (de) Analgetische zusammensetzungen.
HK42781A (en) 4-amino-6,7-dimethoxy-2-(4-(heterocyclocarbonyl)piperozin-1-yl)quinazolines
IT8220611A0 (it) Composizioni farmaceutiche topiche.
DE69500778D1 (de) Emulsion, die stabilisierte Ascorbinsäure enthält
DE3789617D1 (de) Glycerolmonolaurate enthaltende, die Hautpermeabilität vergrössernde Zusammensetzungen.
NL193283B (nl) 4,4-Dialkyl-1-[4-[4-(2-pirimidinyl)-1-piperazinyl]-butyl]-2,6- piperazinedionen.
FI832658L (fi) 2-substituerade 4-amino-6,7-dimetoxikinoliner
NL930098I2 (nl) Cefalosporineverbindingen, hun bereiding en samen stellingen die deze bevatten.
NL190519B (nl) 4-gesubstitueerde fenylazijnzuurverbindingen, alsmede farmaceutische preparaten.
NL990010I2 (nl) Ä3HÜ-imidazo-Ä5,1-dÜ-1,2,3,5-tetrazine-4-on derivaten en farmaceutische samenstellingen, die deze d erivaten bevatten.
IT1190824B (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
DE3576335D1 (de) Chinolincarbonsaeure-derivate.
IT1206502B (it) Composizioni analgesiche e antinfiammatorie migliorate, contenenti caffeina.
FI812539A7 (fi) Substituoituja enantolaktaami- johdannaisia verenpainelääkkeiksi.
IT8221332A0 (it) Composizioni anticonvulsive.
IT7927243A0 (it) Per la loro preparazione e composti triazinonici, procedimenti composizioni farmaceutiche che licontengono.
FI812997A7 (fi) Uusia kinoloniyhdisteitä, jotka ovat terapuettisesti aktiivisia verenpainetta alentavia aineita.
FI810683A7 (fi) Verenpainetaudin vastaiset aineet.
IT8223280A0 (it) Procedimento per la fabbricazione di pezzi finiti da materiali ferritici altamente legati.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee

Effective date: 19950901